NDC 63539-019

SUTENT

Sunitinib Malate

SUTENT is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Sunitinib Malate.

Product ID63539-019_23a46318-098e-48f1-a0cf-413d6a546c73
NDC63539-019
Product TypeHuman Prescription Drug
Proprietary NameSUTENT
Generic NameSunitinib Malate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2006-01-26
Marketing CategoryNDA / NDA
Application NumberNDA021938
Labeler NameU.S. Pharmaceuticals
Substance NameSUNITINIB MALATE
Active Ingredient Strength50 mg/1
Pharm ClassesProtein Kinase Inhibitors [MoA],Kinase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63539-019-01

14 CAPSULE in 1 BOTTLE (63539-019-01)
Marketing Start Date2017-05-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "SUTENT" or generic name "Sunitinib Malate"

NDCBrand NameGeneric Name
0069-0550SUTENTSunitinib malate
0069-0770SUTENTSunitinib malate
0069-0830SUTENTSunitinib malate
0069-0980SUTENTSunitinib malate
63539-017SUTENTSUTENT
63539-019SUTENTSUTENT
0093-8199Sunitinib MalateSunitinib Malate
0093-8224Sunitinib MalateSunitinib Malate
0093-8229Sunitinib MalateSunitinib Malate
0093-8231Sunitinib MalateSunitinib Malate
0378-6678Sunitinib Malatesunitinib malate
0378-6679Sunitinib Malatesunitinib malate
0378-6680Sunitinib Malatesunitinib malate
0378-6681Sunitinib Malatesunitinib malate
16714-676Sunitinib malateSunitinib malate
16714-677Sunitinib malateSunitinib malate

Trademark Results [SUTENT]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SUTENT
SUTENT
78750554 3170173 Live/Registered
C.P. PHARMACEUTICALS INTERNATIONAL C.V.
2005-11-09
SUTENT
SUTENT
78639799 not registered Dead/Abandoned
Pharmacia & Upjohn Company LLC
2005-05-31
SUTENT
SUTENT
76388649 2948764 Live/Registered
C.P. PHARMACEUTICALS INTERNATIONAL C.V.
2002-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.